Report #2841868

Received May 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Not recovered
Vaccinated: May 4, 2025
Onset: May 5, 2025
Days to onset: 1
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	—	—

Symptoms (1)

Paraesthesia

Symptom narrative

Tingling skin which travels from her arms, then to her back, then to her feet/legs; This non-serious case was reported by a consumer via call center representative and described the occurrence of tingling skin in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 04-MAY-2025, the patient received Shingrix. On 05-MAY-2025, 1 days after receiving Shingrix, the patient experienced tingling skin (Verbatim: Tingling skin which travels from her arms, then to her back, then to her feet/legs). The outcome of the tingling skin was not resolved. It was unknown if the reporter considered the tingling skin to be related to Shingrix. It was unknown if the company considered the tingling skin to be related to Shingrix. Additional Information: GSK Receipt Date: 06-MAY-2025 The patient self-reported this case. The patient received her Shingrix vaccine and on next day she began feeling a tingling sensation on her skin, which travelled from her arms, then to her back, then to her feet or legs. The patient refused to provide any additional information.